Skip to main content
Top
Published in: Respiratory Research 1/2012

Open Access 01-12-2012 | Research

Snail promotes an invasive phenotype in lung carcinoma

Authors: Heta Merikallio, Taina Turpeenniemi-Hujanen, Paavo Pääkkö, Riitta Mäkitaro, Kaarteenaho Riitta, Sirpa Salo, Tuula Salo, Terttu Harju, Ylermi Soini

Published in: Respiratory Research | Issue 1/2012

Login to get access

Abstract

Background

Snail is a transcriptional factor which is known to influence the epitheliomesenchymal transition (EMT) by regulating adhesion proteins such as E-cadherin and claudins as well as matrix metalloproteases (MMP).

Methods

To evaluate the functional importance of snail, a transciptional factor involved in EMT in lung tumors, we investigated its expression in a large set of lung carcinomas by immunohistochemistry. Expression of snail and effects of snail knockdown was studied in cell lines.

Results

Nuclear snail expression was seen in 21% of cases this being strongest in small cell lung carcinomas (SCLC). There was significantly greater snail expression in SCLC compared to squamous cell or adenocarcinoma. Positive snail expression was associated with poor survival in the whole material and separately in squamous cell and adenocarcinomas. In Cox regression analysis, snail expression showed an independent prognostic value in all of these groups. In several cell lines knockdown of snail reduced invasion in both matrigel assay and in the myoma tissue model for invasion. The influence of snail knockdown on claudin expression was cell type specific. Snail knockdown in these cell lines modified the expression of MMP2 and MMP9 but did not influence the activation of these MMPs to any significant degree.

Conclusions

The results show that snail plays an important role in the invasive characteristics of lung carcinoma influencing the survival of the patients. Snail knockdown might thus be one option for targeted molecular therapy in lung cancer. Snail knockdown influenced the expression of claudins individually in a cell-line dependent manner but did not influence MMP expressions or activations to any significant degree.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ikenouchi J, Matsuda M, Furuse M, Tsukita S: Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci. 2003, 116: 1959-1967. 10.1242/jcs.00389.PubMedCrossRef Ikenouchi J, Matsuda M, Furuse M, Tsukita S: Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci. 2003, 116: 1959-1967. 10.1242/jcs.00389.PubMedCrossRef
2.
go back to reference Rosivatz E, Becker I, Specht K, Fricke E, Luber B, Busch R, Hofler H, Becker KF: Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol. 2002, 161: 1881-1891. 10.1016/S0002-9440(10)64464-1.PubMedPubMedCentralCrossRef Rosivatz E, Becker I, Specht K, Fricke E, Luber B, Busch R, Hofler H, Becker KF: Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol. 2002, 161: 1881-1891. 10.1016/S0002-9440(10)64464-1.PubMedPubMedCentralCrossRef
3.
go back to reference Barrallo-Gimeno A, Nieto MA: The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development. 2005, 132: 3151-3161. 10.1242/dev.01907.PubMedCrossRef Barrallo-Gimeno A, Nieto MA: The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development. 2005, 132: 3151-3161. 10.1242/dev.01907.PubMedCrossRef
4.
go back to reference Guaita S, Puig I, Franci C, Garrido M, Dominguez D, Batlle E, Sancho E, Dedhar S, De Herreros AG, Baulida J: Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J Biol Chem. 2002, 277: 39209-39216. 10.1074/jbc.M206400200.PubMedCrossRef Guaita S, Puig I, Franci C, Garrido M, Dominguez D, Batlle E, Sancho E, Dedhar S, De Herreros AG, Baulida J: Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J Biol Chem. 2002, 277: 39209-39216. 10.1074/jbc.M206400200.PubMedCrossRef
5.
go back to reference Jorda M, Olmeda D, Vinyals A, Valero E, Cubillo E, Llorens A, Cano A, Fabra A: Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor. J Cell Sci. 2005, 118: 3371-3385. 10.1242/jcs.02465.PubMedCrossRef Jorda M, Olmeda D, Vinyals A, Valero E, Cubillo E, Llorens A, Cano A, Fabra A: Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor. J Cell Sci. 2005, 118: 3371-3385. 10.1242/jcs.02465.PubMedCrossRef
6.
go back to reference Ohkubo T, Ozawa M: The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation. J Cell Sci. 2004, 117: 1675-1685. 10.1242/jcs.01004.PubMedCrossRef Ohkubo T, Ozawa M: The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation. J Cell Sci. 2004, 117: 1675-1685. 10.1242/jcs.01004.PubMedCrossRef
7.
go back to reference Martinez-Estrada OM, Culleres A, Soriano FX, Peinado H, Bolos V, Martinez FO, Reina M, Cano A, Fabre M, Vilaro S: The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells. Biochem J. 2006, 394: 449-457. 10.1042/BJ20050591.PubMedPubMedCentralCrossRef Martinez-Estrada OM, Culleres A, Soriano FX, Peinado H, Bolos V, Martinez FO, Reina M, Cano A, Fabre M, Vilaro S: The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells. Biochem J. 2006, 394: 449-457. 10.1042/BJ20050591.PubMedPubMedCentralCrossRef
8.
go back to reference Kessenbrock K, Plaks V, Werb Z: Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010, 141: 52-67. 10.1016/j.cell.2010.03.015.PubMedPubMedCentralCrossRef Kessenbrock K, Plaks V, Werb Z: Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010, 141: 52-67. 10.1016/j.cell.2010.03.015.PubMedPubMedCentralCrossRef
9.
go back to reference Lin CY, Tsai PH, Kandaswami CC, Lee PP, Huang CJ, Hwang JJ, Lee MT: Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition. Cancer Sci. 2011, 102: 815-827. 10.1111/j.1349-7006.2011.01861.x.PubMedCrossRef Lin CY, Tsai PH, Kandaswami CC, Lee PP, Huang CJ, Hwang JJ, Lee MT: Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition. Cancer Sci. 2011, 102: 815-827. 10.1111/j.1349-7006.2011.01861.x.PubMedCrossRef
10.
go back to reference Orlichenko LS, Radisky DC: Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development. Clin Exp Metastasis. 2008, 25: 593-600. 10.1007/s10585-008-9143-9.PubMedCrossRef Orlichenko LS, Radisky DC: Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development. Clin Exp Metastasis. 2008, 25: 593-600. 10.1007/s10585-008-9143-9.PubMedCrossRef
11.
go back to reference Soini Y: Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours. Histopathology. 2005, 46: 551-560. 10.1111/j.1365-2559.2005.02127.x.PubMedCrossRef Soini Y: Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours. Histopathology. 2005, 46: 551-560. 10.1111/j.1365-2559.2005.02127.x.PubMedCrossRef
12.
go back to reference Soini Y, Kinnula V, Kahlos K, Paakko P: Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura. J Clin Pathol. 2006, 59: 250-254. 10.1136/jcp.2005.028589.PubMedPubMedCentralCrossRef Soini Y, Kinnula V, Kahlos K, Paakko P: Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura. J Clin Pathol. 2006, 59: 250-254. 10.1136/jcp.2005.028589.PubMedPubMedCentralCrossRef
13.
go back to reference Vare P, Loikkanen I, Hirvikoski P, Vaarala MH, Soini Y: Low claudin expression is associated with high Gleason grade in prostate adenocarcinoma. Oncol Rep. 2008, 19: 25-31.PubMed Vare P, Loikkanen I, Hirvikoski P, Vaarala MH, Soini Y: Low claudin expression is associated with high Gleason grade in prostate adenocarcinoma. Oncol Rep. 2008, 19: 25-31.PubMed
14.
go back to reference Soini Y, Tommola S, Helin H, Martikainen P: Claudins 1, 3, 4 and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtype. Virchows Arch. 2006, 448: 52-58. 10.1007/s00428-005-0011-6.PubMedCrossRef Soini Y, Tommola S, Helin H, Martikainen P: Claudins 1, 3, 4 and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtype. Virchows Arch. 2006, 448: 52-58. 10.1007/s00428-005-0011-6.PubMedCrossRef
15.
go back to reference Soini Y: Claudins 2, 3, 4, and 5 in Paget's disease and breast carcinoma. Hum Pathol. 2004, 35: 1531-1536. 10.1016/j.humpath.2004.09.015.PubMedCrossRef Soini Y: Claudins 2, 3, 4, and 5 in Paget's disease and breast carcinoma. Hum Pathol. 2004, 35: 1531-1536. 10.1016/j.humpath.2004.09.015.PubMedCrossRef
16.
go back to reference Takala H, Saarnio J, Wiik H, Soini Y: Claudins 1, 3, 4, 5 and 7 in esophageal cancer: loss of claudin 3 and 4 expression is associated with metastatic behavior. APMIS. 2007, 115: 838-847. 10.1111/j.1600-0463.2007.apm_656.x.PubMedCrossRef Takala H, Saarnio J, Wiik H, Soini Y: Claudins 1, 3, 4, 5 and 7 in esophageal cancer: loss of claudin 3 and 4 expression is associated with metastatic behavior. APMIS. 2007, 115: 838-847. 10.1111/j.1600-0463.2007.apm_656.x.PubMedCrossRef
17.
go back to reference WHO Classification of Tumours. Pathology & Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Edited by: Travis W, Brambilla E, Muller-Hermelink H, Harris C. 2004, Lyon: IARC Press WHO Classification of Tumours. Pathology & Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Edited by: Travis W, Brambilla E, Muller-Hermelink H, Harris C. 2004, Lyon: IARC Press
18.
go back to reference Merikallio H, Kaarteenaho R, Paakko P, Lehtonen S, Hirvikoski P, Makitaro R, Harju T, Soini Y: Impact of smoking on the expression of claudins in lung carcinoma. Eur J Cancer. 2011, 47: 620-630. 10.1016/j.ejca.2010.10.017.PubMedCrossRef Merikallio H, Kaarteenaho R, Paakko P, Lehtonen S, Hirvikoski P, Makitaro R, Harju T, Soini Y: Impact of smoking on the expression of claudins in lung carcinoma. Eur J Cancer. 2011, 47: 620-630. 10.1016/j.ejca.2010.10.017.PubMedCrossRef
19.
go back to reference Olmeda D, Montes A, Moreno-Bueno G, Flores JM, Portillo F, Cano A: Snai1 and Snai2 collaborate on tumor growth and metastasis properties of mouse skin carcinoma cell lines. Oncogene. 2008, 27: 4690-4701. 10.1038/onc.2008.118.PubMedCrossRef Olmeda D, Montes A, Moreno-Bueno G, Flores JM, Portillo F, Cano A: Snai1 and Snai2 collaborate on tumor growth and metastasis properties of mouse skin carcinoma cell lines. Oncogene. 2008, 27: 4690-4701. 10.1038/onc.2008.118.PubMedCrossRef
20.
go back to reference Yang MH, Chang SY, Chiou SH, Liu CJ, Chi CW, Chen PM, Teng SC, Wu KJ: Overexpression of NBS1 induces epithelial-mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer. Oncogene. 2007, 26: 1459-1467. 10.1038/sj.onc.1209929.PubMedCrossRef Yang MH, Chang SY, Chiou SH, Liu CJ, Chi CW, Chen PM, Teng SC, Wu KJ: Overexpression of NBS1 induces epithelial-mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer. Oncogene. 2007, 26: 1459-1467. 10.1038/sj.onc.1209929.PubMedCrossRef
21.
go back to reference Blechschmidt K, Sassen S, Schmalfeldt B, Schuster T, Hofler H, Becker KF: The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients. Br J Cancer. 2008, 98: 489-495. 10.1038/sj.bjc.6604115.PubMedPubMedCentralCrossRef Blechschmidt K, Sassen S, Schmalfeldt B, Schuster T, Hofler H, Becker KF: The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients. Br J Cancer. 2008, 98: 489-495. 10.1038/sj.bjc.6604115.PubMedPubMedCentralCrossRef
22.
go back to reference Hipp S, Walch A, Schuster T, Hofler H, Becker KF: Precise measurement of the E-cadherin repressor Snail in formalin-fixed endometrial carcinoma using protein lysate microarrays. Clin Exp Metastasis. 2008, 25: 679-683. 10.1007/s10585-008-9149-3.PubMedCrossRef Hipp S, Walch A, Schuster T, Hofler H, Becker KF: Precise measurement of the E-cadherin repressor Snail in formalin-fixed endometrial carcinoma using protein lysate microarrays. Clin Exp Metastasis. 2008, 25: 679-683. 10.1007/s10585-008-9149-3.PubMedCrossRef
23.
go back to reference Olmeda D, Jorda M, Peinado H, Fabra A, Cano A: Snail silencing effectively suppresses tumour growth and invasiveness. Oncogene. 2007, 26: 1862-1874. 10.1038/sj.onc.1209997.PubMedCrossRef Olmeda D, Jorda M, Peinado H, Fabra A, Cano A: Snail silencing effectively suppresses tumour growth and invasiveness. Oncogene. 2007, 26: 1862-1874. 10.1038/sj.onc.1209997.PubMedCrossRef
24.
go back to reference Jin H, Yu Y, Zhang T, Zhou X, Zhou J, Jia L, Wu Y, Zhou BP, Feng Y: Snail is critical for tumor growth and metastasis of ovarian carcinoma. Int J Cancer. 2010, 126: 2102-2111.PubMed Jin H, Yu Y, Zhang T, Zhou X, Zhou J, Jia L, Wu Y, Zhou BP, Feng Y: Snail is critical for tumor growth and metastasis of ovarian carcinoma. Int J Cancer. 2010, 126: 2102-2111.PubMed
Metadata
Title
Snail promotes an invasive phenotype in lung carcinoma
Authors
Heta Merikallio
Taina Turpeenniemi-Hujanen
Paavo Pääkkö
Riitta Mäkitaro
Kaarteenaho Riitta
Sirpa Salo
Tuula Salo
Terttu Harju
Ylermi Soini
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2012
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-13-104

Other articles of this Issue 1/2012

Respiratory Research 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine